Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radioligand therapy in combination with CAR T cells overcomes the heterogeneous immunosuppressive prostate tumor microenvironment.

bioRxiv : the preprint server for biology·2026
Same author

Longitudinal Single-Cell RNA-Sequencing Reveals Evolution of Micro- and Macro-states in Chronic Myeloid Leukemia.

Cancer research·2026
Same author

Integrating imaging and mathematical modeling to predict and optimize patient outcomes in oncology.

NPJ systems biology and applications·2026
Same author

Multiomic State-Transitions Reveal Post-Treatment Transcriptome Desynchronization in Acute Myeloid Leukemia.

bioRxiv : the preprint server for biology·2026
Same author

Armored chimeric antigen receptor T-cell therapy targets antigen-heterogeneous glioma.

Cancer research·2026
Same author

Whole-protein screening and multi-modal profiling of antigen-specific CD4<sup>+</sup> T cells at single-cell resolution.

Nature communications·2026

Related Experiment Video

Updated: Jul 28, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.4K

Data driven model discovery and interpretation for CAR T-cell killing using sparse identification and latent

Alexander B Brummer1,2, Agata Xella3, Ryan Woodall1

  • 1Division of Mathematical Oncology, Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, United States.

Frontiers in Immunology
|May 31, 2023
PubMed
Summary

This study applies the SINDy algorithm to discover cell-cell interaction dynamics in cancer therapies. This data-driven approach enhances understanding of chimeric antigen receptor T-cell dynamics for improved treatment efficacy.

Keywords:
CAR T-cellsSINDyallee effectantigen bindingcell therapydynamical systemsglioblastomalatent variables

More Related Videos

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level
08:09

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level

Published on: March 14, 2025

986
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

677

Related Experiment Videos

Last Updated: Jul 28, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.4K
Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level
08:09

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level

Published on: March 14, 2025

986
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

677

Area of Science:

  • Computational Biology
  • Cancer Research
  • Immunotherapy

Background:

  • Quantitative mathematical models are crucial for understanding cell-based cancer therapy efficacy.
  • Validating and interpreting these models requires precise mathematical formulations and experimental data analysis.

Purpose of the Study:

  • To apply the sparse identification of non-linear dynamics (SINDy) algorithm to discover cell-cell interaction dynamics in experimental data.
  • To infer key aspects of CAR T-cell and cancer cell population interactions using latent variable analysis and SINDy.
  • To biologically interpret the discovered model terms in relation to CAR T-cell functions and population dynamics.

Main Methods:

  • Application of the SINDy algorithm to in vitro experimental data of chimeric antigen receptor (CAR) T-cells and patient-derived glioblastoma cells.
  • Integration of latent variable analysis with SINDy for inferring interaction dynamics.
  • Biological interpretation of model terms related to CAR T-cell responses, binding, and density-dependent growth.

Main Results:

  • The first application of SINDy to a real biological system for discovering cell-cell interaction dynamics.
  • Inference of key interaction dynamics between CAR T-cell and cancer cell populations.
  • Biological interpretability of model terms, revealing insights into CAR T-cell functional responses and population dynamics.

Conclusions:

  • The data-driven SINDy approach provides unique insights into CAR T-cell dynamics compared to traditional model-first methods.
  • SINDy has the potential to improve the implementation and efficacy of CAR T-cell therapy through enhanced understanding.
  • This work demonstrates the utility of SINDy for advancing cell-based cancer therapies.